Heart and Blood Diseases

All Conditions

Neoplasms

Skin and Connective Tissue Diseases

Symptoms and General Pathology

Musculoskeletal Diseases

Nutritional and Metabolic Diseases

Coronary Artery Disease

Myocardial Ischemia

Coronary Disease

Heart Diseases

Breast Neoplasms

Syndrome

Osteoporosis

Bone Diseases

Bone Diseases, Metabolic

Metabolic Diseases

Menopause

All Drugs and Chemicals

Reproductive Control Agents

Antineoplastic Agents

Hormones

Progestins

Estradiol 17 beta-cypionate

Estradiol 3-benzoate

Estradiol

Polyestradiol phosphate

Progesterone

Phytoestrogens

Medroxyprogesterone Acetate

Medroxyprogesterone

Estrogens

Hormone Antagonists

Contraceptive Agents

Contraceptive Agents, Hormonal

Contraceptive Agents, Female

1 mg estradiol valerate, once a day, for 28 days, since the 17th day of taking estradiol valerate adding 4mg medroxyprogesterone acetate, once a day, for 12 days. 28 days forms one cycle. The anticipated duration is 24cycles.

estradiol valerate, 1mg\*21/box medroxyprogesterone acetate, 2mg\*100/bottle

1 mg estradiol valerate, once a day, for 28 days, since the 17th day of taking estradiol valerate adding 200mg progesterone capsule, once a day, for 12 days. 28 days forms one cycle. The anticipated duration is 24cycles.

estradiol valerate, 1mg\*21/box progesterone capsule, 100mg\*6/box

1 tablet of cimicifuga rhizoma extract, tid 100mg\*15\*2/box The anticipated duration is 2 years.

Participants are given estradiol and synthetic progestin.

estradiol plus MPA

Ximingting Tablet

Participants are given estradiol and natural progesterone.

estradiol plus progesterone

Tingping Zheng, Bachelor Degree

Wei Xue, Bachelor Degree

Aijun Sun, PH.D M.D

This study is to evaluate the benefit/risk of hormone replacement treatment among early menopausal women in China. This is a multi-centre, random, prospective study.

Multi-centre Clinical Trial on Hormone Replacement Treatment in China

height, weight, heart rate, BP, gynecological examination

lipid profiles, high-sensitivity C-reactive protein, Hemoglobin A1C, fasting glucose, fasting insulin, blood pressure, waistline, hipline, body composition, electrocardiogram, incidence of coronary heart disease

Mammography, palpation of breast, incidence of breast cancer

mini-mental state examination, hospital anxiety and depression scale

Kupperman menopause index, RAND36 Menopause-Specific quality of life questionaire

Peking Union Medical College Hospital

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization	Link
Multi-centre Clinical Trial on Hormone Replacement Treatment in China	NCT01698164	Menopausal Synd... Cardiovascular ... Osteoporosis Breast Cancer	estradiol plus ... Ximingting Tabl... estradiol plus ...	40 Years - 60 Years	Peking Union Medical College Hospital
Multi-centre Clinical Trial on Hormone Replacement Treatment in China	NCT01698164	Menopausal Synd... Cardiovascular ... Osteoporosis Breast Cancer	estradiol plus ... Ximingting Tabl... estradiol plus ...	40 Years - 60 Years	Peking Union Medical College Hospital

Spots Global Cancer Trial Database for had

Every month we try and update this database with for had cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Spots Global Cancer Trial Database for had

Every month we try and update this database with for had cancer trials from around the world to help patients and their families find trials that might be right for them. We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

Every month we try and update this database with for had cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.